Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

54
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
54
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ID93 + GLA-3M-052-LS vaccine candidate administered by heterologous routes improves BCG efficacy against TB.

Frontiers in immunology·2026
Same author

Structure and immunological activity of QS-21 variant from <i>Quillaja saponaria</i> aerial biomass.

Frontiers in immunology·2026
Same author

Mucosal vaccination in mice provides protection from diverse respiratory threats.

Science (New York, N.Y.)·2026
Same author

The ID93 + GLA-3M-052-LS vaccine candidate elicits mucosal and systemic immunogenicity and protective efficacy against <i>Mycobacterium tuberculosis</i> challenge in BCG-primed Collaborative Cross inbred mice.

bioRxiv : the preprint server for biology·2025
Same author

Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans.

Cell·2025
Same author

A Thermostable nasal spray dried COVID vaccine candidate.

International journal of pharmaceutics·2025
Same journal

Correction: Mohite et al. Bioactive Compound-Fortified Nanomedicine in the Modulation of Reactive Oxygen Species and Enhancement of the Wound Healing Process: A Review. <i>Pharmaceutics</i> 2025, <i>17</i>, 855.

Pharmaceutics·2026
Same journal

Metal Nanoparticle-Reinforced Hydrogels Applied in the Inhibition of Clinical Pathogens: Structural Features, Mechanisms, and Biomedical Prospects.

Pharmaceutics·2026
Same journal

Development and Evaluation of a Physiologically Based Pharmacokinetic Model for Cipepofol Across Diverse Clinical Populations.

Pharmaceutics·2026
Same journal

Artificial Intelligence in Nanopharmaceutical Development: From Predictive Design to Clinical Translation.

Pharmaceutics·2026
Same journal

Textilinin-1, a Snake Venom-Derived Kunitz-Type Protease Inhibitor, Accelerates Wound Healing Through Anti-Inflammatory, Antibacterial, and Pro-Regenerative Activities.

Pharmaceutics·2026
Same journal

Metformin and cRGDfc-Modified Nanoparticles Loaded with Curcumin for Age-Related Macular Degeneration: In Vitro Pharmacodynamics and Molecular Mechanisms.

Pharmaceutics·2026
See all related articles

Related Experiment Video

Updated: Jul 20, 2025

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

1.9K

Practical Considerations for Next-Generation Adjuvant Development and Translation.

William R Lykins1, Christopher B Fox1

  • 1Access to Advanced Health Institute, Seattle, WA 98102, USA.

Pharmaceutics
|July 29, 2023
PubMed
Summary
This summary is machine-generated.

Developing new vaccine adjuvants faces long timelines due to translation, safety, and manufacturing challenges. Early integration of tools and modified development approaches can accelerate the creation of practical, accessible adjuvant-containing vaccines.

Keywords:
adjuvantsdesign of experimentsformulationfuture perspectivesmucosal vaccinenatural product discoveryroute of administrationsustainabilitysystems immunologyvaccine development

More Related Videos

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.7K
Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion&#45;Encapsulated Retinoic Acid System for Mucosal Vaccination
06:02

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Published on: February 23, 2024

711

Related Experiment Videos

Last Updated: Jul 20, 2025

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

1.9K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.7K
Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion&#45;Encapsulated Retinoic Acid System for Mucosal Vaccination
06:02

Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

Published on: February 23, 2024

711

Area of Science:

  • Vaccinology
  • Pharmaceutical Development
  • Biotechnology

Background:

  • Growing academic and industry interest in vaccine adjuvants for novel vaccine modalities.
  • Significant delays in vaccine adjuvant development timelines from discovery to clinical approval.
  • Key challenges include inter-species translation, safety/reactogenicity concerns, and scalable raw material sourcing.

Purpose of the Study:

  • To review the current state of vaccine adjuvant technologies.
  • To provide guidance on approaching and applying adjuvant technologies in new vaccine development.
  • To identify factors and tools for earlier integration to enhance clinical success.

Main Methods:

  • Comprehensive literature review of current adjuvant technologies and development practices.
  • Analysis of common challenges in vaccine adjuvant translation and manufacturing.
  • Postulation of modified development strategies for improved clinical outcomes.

Main Results:

  • Adjuvant development is hindered by translational complexities, safety evaluations, and supply chain issues.
  • Current approaches may not adequately address the unique needs of novel vaccine modalities.
  • Earlier consideration of specific tools and strategic planning is crucial for success.

Conclusions:

  • Implementing modified development practices and early-stage strategic planning can overcome current adjuvant development hurdles.
  • These changes aim to improve the accessibility and practicality of adjuvant-containing vaccine products.
  • A proactive approach is recommended to streamline the journey from adjuvant discovery to approved vaccine.